Black Rock Inc. Bridge Bio Pharma, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 12,448,272 shares of BBIO stock, worth $637 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,448,272
Previous 10,466,935
18.93%
Holding current value
$637 Million
Previous $324 Million
2.57%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
188MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$950 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$844 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$679 Million22.63% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$475 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA7.9MShares$405 Million1.53% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.59B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...